More young adults are getting colorectal cancer. What makes their tumors different?

A study in Nature Medicine reveals that colorectal tumors in patients under 50 have different cellular compositions and gene activity compared to older patients. This research provides potential insights into why the disease is becoming more aggressive and prevalent in younger populations.
Why it matters
Understanding the biological differences in early-onset cancer is essential for developing targeted treatments and improving screening protocols for younger adults.
What can scientists discover by examining, cell by cell, a colorectal tumor from a 40-year-old alongside one from a 70-year-old? A new study published in Nature Medicine found that colorectal cancers in patients under 50 differ from those in older patients in both their cellular composition and gene activity. In the most common subtype of the disease, tumors from younger patients contained a higher proportion of supporting cells relative to cancer cells. Those differences may offer clues to why the disease can sometimes behave more aggressively at a younger age. Researchers from Massachusetts General Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard mapped gene activity in more than 850,000 cells from 189 tumors. According to the American Cancer Society, colorectal cancer incidence among Americans under 50 increased by 2.9% each year between 2013 and 2022.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in